4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-245259
10% owner sold 18,572 shares at $40.05 ($743,753)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. 10% owner | 2026-05-26 | Sale 10b5-1 | −18,572 | $40.05 | $743,753 | 6,280,525 | D: show line 1 in the form |
| Open-market sales · 18,572 sh · avg $40.05 · $743,753 | |||||||
Loading xslF345X06/ownership.xml…